Scientific Program
Antibody Therapeutics Conference 2019
New Generation Immunotherapy: from Discovery to Development!
(CAR-T, ADC, Immuno-Oncology)
Venue:
南港六福萬怡酒店超新星廳 (台北市南港區忠孝東路七段359號7樓)
Supernova Ballroom, Courtyard by Marriott® Taipei, Taiwan
Time:
11/7-8, 2019
11/7 Thursday
Time | Topic and Speaker | |||
---|---|---|---|---|
13:00-13:30 | Registration | |||
13:30-13:40 | Opening Remarks Lawrence Gan, Ph.D. 甘良生 理事長 Director of Taiwan Antibody Association; President/CEO, Foresee Pharmaceuticals Wei-kuang Chi, Ph.D. 紀威光 副執行長 Vice President, Executive Director, Institute of Pharmaceutics, Development Center for Biotechnology |
|||
13:40-13:45 |
Chimeric Antigen Receptor T Cells (CAR-T) |
|
||
13:45-14:35 | Keynote Speaker Tackling Heterogeneity in Glioblastoma with CAR T CellsBryan D. Choi, M.D., Ph.D.Cellular Immunotherapy Program, Cancer Center, Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA |
|||
14:35-15:15 | CAR T Cell Therapy for B-Cell MalignanciesYu-Hsiang Chang ,M.D., Ph.D. 張裕享 醫師Tai Chen Stem Cell Therapy Center; National Taiwan University Hospital |
|||
15:15-15:40 | Break | |||
15:40-16:20 | Multiple Carcinoma Targetable CAR for Immune Cell TherapyShao Chih Chiu, Ph.D. 邱紹智 博士Graduate Institute of Biomedical Sciences, China Medical University , Center for Cell Therapy, China Medical University Hospital |
|||
16:20-17:00 |
Antibody-Drug Conjugates (ADC) |
Antibody-Drug Conjugates Developed with Phage-Displayed Synthetic Antibody Libraries and High Throughput Functional AssaysAn-Suei Yang, Ph.D. 楊安綏 博士Research Fellow, Genomics Research Center, Academia Sinica |
||
17:00-17:05 | Closing Remarks |
11/8 Friday
Time | Topic and Speaker | |||
---|---|---|---|---|
9:00-9:15 | Registration | |||
9:15-9:20 | Antibody-Drug Conjugates ADC |
|
||
9:20-10:10 | Keynote SpeakerNovel Globo H-Targeting Antibody-Drug Conjugate with Binding Specificity and Anti-Tumor Efficacy in Multiple Cancer TypesMing-Tain Lai, Ph.D. 賴明添 博士Chief Scientific Officer, OBI Pharma, Inc. |
|||
10:10-10:50 |
Site-Specific Trimannosyl Conjugation and ADC Capability in DCBShih-Hsien Chuang, Ph.D. 莊士賢 博士Director, Medicinal Chemistry Department, Institute of Pharmaceutics, Development Center for Biotechnology |
|||
10:50-11:20 | Break | |||
11:20-11:25 | Immuno-Oncology (IO) |
|
||
11:25-12:05 | The Impact of Tumor Microenvironment on Pancreatic CancerYan-Shen Shan, M.D., Ph.D. 沈延盛 院長Distinguished Professor and Surgeon Dean, College of Medicine, Institute of Clinical Medicine, NCKU Department of Surgery, NCKUH |
|||
12:05-14:00 | Taiwan Antibody Association Member Meeting 公布第三屆理監事當選名單 Lunch Break |
|||
14:00-14:40 | Immuno-Oncology (IO) |
Tumor Localized ImmunotherapyKeng-Li Lan, M.D., Ph.D. 藍耿立 醫師Associate Professor, Institute of Traditional Medicine, School of Medicine, National Yang-Ming University; Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital |
||
14:40-15:20 | Targeting Neoantigens for Precision Immune Cell TherapyShuen-Iu Hung, Ph.D. 洪舜郁 博士Professor/Investigator, Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital |
|||
15:20-15:50 | Break | |||
15:50-16:40 | Keynote Speaker
Engineering Cancer ImmunotherapyCheng-I Wang, Ph.D.Head of the Human Monoclonal Antibody Technology Platform, Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) |
|||
16:40-16:45 | Closing Remarks |